Rigel Reports Second Quarter 2022 Financial Results and Provides Business Update
Go back to Rigel Reports Second Quarter 2022 Financial Results and Provides Business Update| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 46.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.96 | 52 Week High | $4.38 | |||
| Open | $46.96 | 52 Week Low | $1.88 | |||
| Day High | $46.96 | P/E | N/A | |||
| Day Low | $46.96 | EPS | $-1.12 | |||
| Volume | 77 | |||||
